發佈時間：2026-03-11 標題名稱：[轉知_訊息] 13th HTAsiaLink Conference 2026 發佈內容：
We are excited to announce that the 13th HTAsiaLink Conference is heading to Taipei! We are now calling for abstract submissions under the theme: "A Step Forward – Powering Policy Impact with HTA in Asia."
As we strive to bridge the gap between evidence and policy, we invite you to share your latest research and insights with the HTAsiaLink community.
Key Dates to Remember:
| Ÿ Conference Date: | 1 September 2026 to 4 September 2026 |
| Ÿ Venue: | Taipei International Convention Center (TICC), Taipei, Taiwan |
| Ÿ Abstract Submission Date | 4 March 2026 to 10 April 2026 |
| Ÿ Notification of Acceptance: | May 2026 |
Important Note: This conference is open to members and associate members of HTAsiaLink network. Please note that abstracts will only be accepted from authors who can commit to attending and presenting their abstract in-person at the HTAsiaLink Conference 2026. Participation is free of charge for our members; however, all attendees are responsible for their own travel and accommodation costs.
For further details regarding abstract submission, we warmly invite you to visit our website at HTAsiaLink 2026 Conference.
We would also appreciate your assistance in circulating this announcement among your colleagues and professional networks.
We look forward to receiving your submissions and welcoming you to the heart of Taipei for this impactful event.
Best wishes,
13th HTAsiaLink Annual Conference 2026 Organizing Committee
sec@htasialink2026.org (cc: HTAsiaLink_2026@cde.org.tw)
Division of Health Technology Assessment
Center for Drug Evaluation (CDE), Taiwan
